Environmental Engineering Reference
In-Depth Information
In this chapter, we have summarized the recent developments in the field of
liposomal nanomedicine under the following topics: (i) diverse formulation of
liposome nanomedicine, (ii) agents delivered by nanoliposomes, (iii) nanoliposomes
and their application as vaccines, (iv) liposomal nanomedicine in targeting diseases,
(v) liposomal nanomedicine and stem cell therapy, (vi) their application in preclinical
and clinical studies, risks, and (vii) safety issues.
Abbreviations
5-FU
5-Fluorouracil
aHSC
Allogeneic hematopoietic stem cell
aHSCRs
Allogeneic hematopoietic stem cell recipients
aHSCT
Allogeneic hematopoietic stem cell transplantation
AL
Anionic liposomes
AmB
Amphotericin B
ASOs
Antisense oligonucleotides
Au
Gold
BC
Breast cancer
BCSCs
Breast cancer stem cells
CAS
Caspofungin
CDDP
cis
-Diamminedichloroplatinum(II). CDDP, a chemotherapy drug, is
another name for Cisplatin or cisplatinum
cGMP
Cyclic guanosine monophosphate
CHEMS
Cholesteryl hemisuccinate
CHOL
Cholesterol
CLP
Cationic liposomes
CS/DNA
Chitosan/DNA
CSF
Colony-stimulating factor
CSCs
Cancer stem cells
CTL
Cytotoxic T cell
CXC
A subfamily of chemokine
DCP
Dicetyl phosphate
DexP
Dexamethasone palmitate
DMRIE/
DOPE
1,2-Dimyristyloxy-propyl-3-dimethyl-hydroxy ethyl ammonium
bromide/dioleoylphosphatidylethanolamine
DMSO
Di methyl sulfoxide
DOPC
Dioleoyl phosphatidyl Choline
DOPE
Dioleoyl phosphatidyl ethanolamine
DOTAP
1,2-Dioleoyl-3-trimethylammonium-propane
DOX
Doxorubicin
DPPC
Di-palmitoyl phosphatidyl choline
DTPA
Diethylene triamine pentaacetic acid
ELISA
Enzyme-linked immunosorbent assay
